Laparoscopic Insufflation Devices Market Outlook: Rise in Demand of Robot-assisted Surgery to Drive Market Growth to US$ 2.00 Billion by 2031

As per the latest market research by Business Market Insights (BMI), the research report "Laparoscopic Insufflation Devices Market Outlook Size and Forecast (2021–2031)" forecasts how the market is set to surge 80.4% by 2031 as growing demand for bariatric surgeries reshapes the laparoscopic insufflation devices ecosystem. The report highlights technological advancements in gas regulation, revolutionizing the global landscape of laparoscopic insufflation devices.

The report forecasts the market to expand from US$ 1.11 billion in 2024 to US$ 2.00 billion by 2031, registering a robust CAGR of 8.79% over the 2025–2031 period.

The​‍​‌‍​‍‌​‍​‌‍​‍‌ improvements to technology in gas regulation have been a major factor in the exponential growth of the laparoscopic insufflation devices market. These have led to enhanced surgical precision, patient safety, and procedural efficiency. Present-day insufflation devices have intelligent flow control mechanisms as one of their features. These flow controls adjust CO₂ delivery depending on the intra-abdominal pressure automatically, thus the risk of over-insufflation and the complications associated are minimized. Usually, these devices come with point-of-care pressure measurement and feedback control as well, enabling surgeons to keep a stable pneumoperitoneum throughout the procedures even when they are exchanging instruments or doing suction. The adoption of smoke evacuation and filtration technologies integrated with insufflation devices has further enhanced the visibility of the surgical field while aiding the maintenance of the correct pressure. Moreover, low-pressure insufflation methods supported by sophisticated gas regulation algorithms have been found to lessen the post-operative pain and speed up the patient recovery process, thus, they are becoming more and more popular in enhanced recovery after surgery (ERAS) protocols. Small and portable insufflators with digital interfaces and programmable settings are also becoming popular, especially in outpatient and ambulatory surgical ​‍​‌‍​‍‌​‍​‌‍​‍‌centers.

Overview of report findings

Market Growth

The Laparoscopic Insufflation Devices Market is projected to grow from US$ 1.11 billion in 2024 to US$ 2.00 billion by 2031, registering a compound annual growth rate (CAGR) of 8.79% between 2025 and 2031.

The growth in the adoption of laparoscopic bariatric surgeries, and emphasis on patient comfort during procedures are key factors propelling market growth. Advancements in gas regulations are transforming the landscape of laparoscopic insufflation devices.

Growth in the Adoption of Laparoscopic Bariatric Surgeries

One​‍​‌‍​‍‌​‍​‌‍​‍‌ of the major factors impelling the laparoscopic insufflation devices market is the greater adoption of laparoscopic bariatric surgeries, which mainly require a safe and effective pneumoperitoneum that is accurate and stable. Given that obesity is becoming a significant public health issue worldwide, healthcare systems are embedding bariatric surgery in their treatment plans at a rapid pace, which eventually results in the increase of laparoscopic procedures such as sleeve gastrectomy and gastric bypass. These operations require the use of modern insufflation equipment that can keep the intra-abdominal pressure at a certain level, can handle smoke evacuation, and can also support the extension of the procedural duration. Consequently, hospitals and surgery centers are equipping themselves with advanced insufflation instruments that provide features such as automated gas flow control, built-in filtration, and can be used with both standard and robotic-assisted platforms. Moreover, the introduction of the enhanced recovery after surgery (ERAS) programs has brought about a rapid change to the preference of minimally invasive techniques, in which insufflation is indispensable for lessening the operative trauma and post-operative complications. The number of surgeons trained and certified in laparoscopic bariatric surgery is also on the rise, which means more surgeons will be available, and procedural volumes will increase. Besides that, medical tourists and the private sector in emerging markets are the factors that drive the need for reliable and affordable insufflation systems that are designed specifically for the bariatric applications. As clinical guidelines increasingly recommend surgical intervention as the best solution for long-term weight management, the demand for advanced insufflation technology becomes the central issue that determines the success of the procedure, thus this segment being positioned as the main enabler for the further development of laparoscopic bariatric ​‍​‌‍​‍‌​‍​‌‍​‍‌care.

Focus on Patient Comfort During Procedures

The​‍​‌‍​‍‌​‍​‌‍​‍‌ focus on patient comfort throughout the procedures has essentially led to the growth of the market for laparoscopic insufflation devices as healthcare providers are looking for success not only during the operation but also in the post-operative recovery and overall patient experience. The advanced insufflation devices are equipped with sophisticated pressure regulation and slow-flow CO₂ delivery units that help in lessening peritoneal irritation and discomfort. These developments play an important role in reducing the patient's post-operative pain, decreasing the cases of shoulder-tip pain, and quickening recovery, thus corresponding to enhanced recovery after surgery (ERAS) protocols. Also, the devices that ensure stable pneumoperitoneum during the time they associate with smoke evacuation as well as temperature-controlled gas delivery allow the creation of a more physiologically neutral environment, which is, therefore, beneficial to the patient. Hospitals and surgical centers are turning to insufflation technologies that facilitate low-pressure techniques have been proven in clinical trials to lead to less analgesic consumption and shorter hospital stays. The focus on patient-centric care models and value-based reimbursement schemes are also some of the factors that influence decisions on purchases, with institutions that prioritize such systems contributing to better comfort scores and less occurrence of complications. Besides this, the demand for small, powerful insufflation devices which can provide patient comfort without weakening the integrity of the procedure is increasing as more minimally invasive operations are being performed in outpatient settings. This change is indicative of the overall surgical care revolution where comfort, safety, and recovery are considered to be the interrelated metrics of success, thus advanced insufflation technology becomes not only a clinical necessity but also a strategic asset in contemporary healthcare ​‍​‌‍​‍‌​‍​‌‍​‍‌delivery.

Geographic Insights

North​‍​‌‍​‍‌​‍​‌‍​‍‌ America is the largest region in the laparoscopic insufflation devices market. This is due to the advanced healthcare infrastructure, a large number of surgeries, and a wide application of minimally invasive procedures to different specialties. The dominance of the market is further supported by the presence of top medical device manufacturers and a strong reimbursement framework. Europe is the second-largest region and is mainly influenced by factors such as regulatory harmonization, well-developed public healthcare systems, and growing demand for laparoscopic surgeries among elderly populations. Hospitals in Western and Central Europe are increasingly purchasing smart insufflation devices that help them to achieve their environmental and clinical efficiency goals. The Asia Pacific region is, however, the fastest-growing market for laparoscopic insufflation devices. This growth is primarily attributed to a rapid expansion of the healthcare sector, a rise in the adoption of minimally invasive techniques, and government-supported surgical modernization programs. China, India, and Southeast Asian countries are undergoing a substantial increase in the number of laparoscopic surgeries which is also being facilitated by the growth of medical tourism and private sector investment. Together, these regional factors create a globally competitive and innovation-driven market ​‍​‌‍​‍‌​‍​‌‍​‍‌landscape.

Market Segmentation

• Based on Product, the market is segmented into CO₂ Insufflators, Warm Gas Insufflators, and Insufflation Tubing and Accessories. The CO₂ Insufflators segment dominated the market in 2024.
• Based on Application, the market is segmented into General Surgery, Bariatric Surgery, Gynaecological Surgery, Colorectal Surgery, and Other Applications. The Bariatric Surgery segment dominated the market in 2024.
• Based on End User, the market is segmented into Hospitals and Clinics, and Ambulatory Surgical Centers. The Hospitals and Clinics dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Laparoscopic Insufflation Devices Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic Plc
2. Johnson & Johnson
3. Olympus Corp
4. Stryker Corp
5. Karl Storz SE & Co KG
6. Boston Scientific Corp

Trending Topics: Smart insufflation systems, Low-pressure laparoscopic techniques, Integrated smoke evacuation, Robotic-assisted laparoscopic surgery, AI-enabled gas flow regulation, Reusable insufflation components, Outpatient laparoscopic procedures, Bariatric surgery demand, Sustainability in surgical devices, Enhanced Recovery Protocols (ERAS)

Global Headlines

• " Stryker Unveils PneumoClear for Robotic Surgery - In February 2024, Stryker launched PneumoClear, a state-of-the-art insufflation system optimized for robotic and laparoscopic procedures. The device incorporates intelligent gas flow algorithms, temperature-controlled CO₂ delivery, and advanced safety features to minimize patient discomfort and surgical complications. PneumoClear is part of Stryker’s broader strategy to integrate smart technologies into the operating room ecosystem."
• " Olympus Launches UHI-4 Insufflation System - In April 2022, Olympus unveiled the UHI-4, a next-generation laparoscopic insufflation system designed to deliver enhanced flow control, improved smoke evacuation, and precise pressure regulation. The device supports a wide range of minimally invasive procedures and is engineered to maintain stable pneumoperitoneum even during complex surgeries. Its launch marked a significant upgrade over previous models, reflecting Olympus’s commitment to surgical innovation and patient safety."

Conclusion

The​‍​‌‍​‍‌​‍​‌‍​‍‌ global laparoscopic insufflation devices market is set to maintain its growth for several years. The main factors leading this growth are the increasing practice of laparoscopic bariatric surgeries, the continuous innovation in gas regulation technology, and the growing concern for the patient's comfort during the procedure. These factors are not only changing the standards of surgery but also increasing the demand for advanced insufflation systems that provide precision, safety, and patient recovery facilitation. Nevertheless, the growth of the market is impeded by issues such as the high cost of the equipment and training and the risk of complications due to the device, thus the adoption rate in resource-constrained areas will be low. In spite of these limitations, the market offers substantial potentials through the inventions of integrated insufflation and smoke evacuation units, the spread of ambulatory surgical centers, and the rising preference for single-use devices that help in cross-contamination reduction and maintenance alleviation. The main trends such as the use of heated and humidified insufflation systems, the growth in usage of the small and portable devices, and the increasing environmental concern are some of the factors that are influencing product innovation and procurement strategies. This market is becoming more patient-centric, technologically advanced, and sensitive to global healthcare ​‍​‌‍​‍‌​‍​‌‍​‍‌shifts.